|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1997-8-21
|
|
pubmed:abstractText |
Bloodstream infection related to short-term use of noncuffed central venous catheters is a common and serious problem. Technologic innovations to reduce the risk for these infections are needed.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0003-4819
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
127
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
257-66
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9265424-Adult,
pubmed-meshheading:9265424-Aged,
pubmed-meshheading:9265424-Anti-Infective Agents, Local,
pubmed-meshheading:9265424-Catheterization, Central Venous,
pubmed-meshheading:9265424-Catheters, Indwelling,
pubmed-meshheading:9265424-Chlorhexidine,
pubmed-meshheading:9265424-Cost-Benefit Analysis,
pubmed-meshheading:9265424-Cross Infection,
pubmed-meshheading:9265424-DNA, Bacterial,
pubmed-meshheading:9265424-DNA, Viral,
pubmed-meshheading:9265424-Female,
pubmed-meshheading:9265424-Humans,
pubmed-meshheading:9265424-Male,
pubmed-meshheading:9265424-Middle Aged,
pubmed-meshheading:9265424-Risk,
pubmed-meshheading:9265424-Sepsis,
pubmed-meshheading:9265424-Silver Sulfadiazine,
pubmed-meshheading:9265424-Treatment Outcome
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
|
|
pubmed:affiliation |
University of Wisconsin Hospital and Clinics-H4/574, Madison 53792, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
